CRINONE® 8% (progesterone gel) and PROCHIEVE® 8% (progesterone gel) are two brand names for our vaginel gel products using our drug delivery system.
Uses include progesterone support in some women to:
Adverse events with any of Columbia Laboratories' products can be reported to us at (866) 566-5636 x2
Full Prescribing Information
PROCHIEVE is indicated for progesterone supplementation or replacement as part of an Assisted Reproductive Technology (ART) treatment for infertile women with progesterone deficiency.
The most common side effects of PROCHIEVE include breast enlargement, constipation, somnolence, nausea, headache, and perineal pain. PROCHIEVE is contraindicated in patients with active thrombophlebitis or thromboembolic disorders, or a history of hormone-associated thrombophlebitis or thomboembolic disorders, missed abortion, undiagnosed vaginal bleeding, liver dysfunction or disease, and known or suspected malignancy of the breast or genital organs.